glp-1 receptor agonists adverse effects Frontiers The Role of GLP-1RA Medications
Description
Wilding JPH, Calanna S, Kushner RF
She recommended maintaining a body mass index (BMI) between 18.5 and 24.8, ideally with regular exercise
153 MaliniNARoy GeorgeK
Mazdutide: A Dual GLP-1/Glucagon Receptor Agonist in Early Clinical Evidence Mazdutide (IBI362) is a novel dual GLP-1 and glucagon receptor agonist designed to integrate appetite suppression with increased energy expenditure
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Yusuf Z.I., Dongarwar D., Yusuf R.A., Bell M., Harris T., Salihu H.M
Physiol Rev (2007) 87:140939
